Philipp Reichert

Years Active: 2020-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Luise Grab, Peter S Kim, Lukas John, Kamlesh Bisht, Hongfang Wang, Anja Baumann, Helgi Van de Velde, Irene Sarkar, Debarati Shome, Philipp Reichert, Calin Manta, Stefanie Gryzik, Rogier M Reijmers, Niels Weinhold, Marc S Raab
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells 13 (10) (2024)
Anna Luise Grab, Peter S Kim, Lukas John, Kamlesh Bisht, Hongfang Wang, Anja Baumann, Helgi Van de Velde, Irene Sarkar, Debarati Shome, Philipp Reichert, Calin Manta, Stefanie Gryzik, Rogier M Reijmers, Niels Weinhold, Marc S Raab
Pre-Clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/Refractory Multiple Myeloma. Cells 13 (10) (2024)
Katharina Kriegsmann, Michael Hundemer, Nicole Hofmeister-Mielke, Philipp Reichert, Calin-Petru Manta, Mohamed H S Awwad, Sandra Sauer, Uta Bertsch, Britta Besemer, Roland Fenk, Mathias Hänel, Markus Munder, Katja C Weisel, Igor W Blau, Andreas Neubauer, Carsten Müller-Tidow, Marc S Raab, Hartmut Goldschmidt, Stefanie Huhn, null For The German-Speaking Myeloma Multicenter Group Gmmg
Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment. Cancers 12 (8) (2020)

Philipp Reichert.css-eqlu8i{font-size:small;padding-left:4px;}